Related Experiment Video
Updated: Jun 5, 2026
Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
Glioblastoma stem cells
Ghazaleh Tabatabai1, Michael Weller
1Laboratory of Molecular Neurooncology, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. ghazaleh.tabatabai@usz.ch
Abstract:
Glioblastomas are highly malignant primary brain tumors with one of the worst survival rates among all human cancers. With a more profound understanding of the cellular and molecular mechanisms of tumor initiation and acquired resistance to conventional radio- and chemotherapy, novel therapeutic targets might be discovered to optimize therapeutic approaches. In this regard, the identification of a small cellular subpopulation, called glioblastoma stem cell or stem-like cells or glioma-initiating cells or brain tumor propagating cells, has gained attention. In this article, we briefly summarize the current state of knowledge about this tumor cell population and discuss future directions for basic and clinical research.
Insights
Glioblastoma stem cells, a small subpopulation of brain tumor cells, are key to understanding tumor growth and resistance. Further research into these cells may reveal new therapeutic targets for glioblastoma treatment.
Area of Science:
- Neuro-oncology
- Cancer Stem Cell Biology
- Molecular Oncology
Background:
- Glioblastomas are aggressive primary brain tumors with poor prognoses.
- Understanding tumor initiation and treatment resistance is crucial for improving outcomes.
- Glioblastoma stem cells (GSCs) represent a critical cellular component in glioblastoma.
Purpose of the Study:
- To summarize current knowledge on glioblastoma stem cells.
- To discuss the implications of GSCs in glioblastoma biology.
- To outline future research directions for GSCs in basic and clinical settings.
Main Methods:
- Review of existing literature on glioblastoma stem cells.
- Analysis of cellular and molecular mechanisms of glioblastoma initiation and resistance.
- Synthesis of current findings and identification of research gaps.
Main Results:
- Glioblastoma stem cells are recognized as a distinct subpopulation driving tumor growth.
- These cells possess self-renewal and differentiation capabilities, contributing to tumor heterogeneity.
- GSCs are implicated in resistance to conventional therapies like radiotherapy and chemotherapy.
Conclusions:
- Glioblastoma stem cells are a significant focus for understanding and treating glioblastoma.
- Targeting GSCs offers a promising strategy for novel therapeutic approaches.
- Continued basic and clinical research is essential to translate GSC knowledge into effective treatments.
